Form 4 for RMD ResMed|
Accepted 2022-11-09 00:00:00 ET · period of report 2022-11-07 · accession 0001127602-22-025209 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-09 | 2022-11-07 | RMD | Sandercock Brett | CFO | S - Sale | $212.02 | -4,000 | 106.3K | -4% | -$848.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-11-07 | S | D | 4,000 | $212.02 | 106,303 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $212 to $212.04. The price reported above reflects the weighted average sale price. (F2) Includes 30.50 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan. |